@article{mielke_sample_2018,
  title = {Sample {{Size}} for {{Multiple Hypothesis Testing}} in {{Biosimilar Development}}},
  author = {Mielke, Johanna and Jones, Byron and Jilma, Bernd and K{\"o}nig, Franz},
  year = {2018},
  month = jan,
  journal = {Statistics in Biopharmaceutical Research},
  volume = {10},
  number = {1},
  pages = {39--49},
  issn = {1946-6315},
  doi = {10.1080/19466315.2017.1371071},
  urldate = {2022-08-17},
  langid = {english}
}

@Misc{Champely2020,
  author       = {Stéphane Champely},
  title        = {pwr: Basic Functions for Power Analysis},
  year         = {2020},
  howpublished = {R package version 1.3-0},
  url          = {https://github.com/heliosdrm/pwr}
}

@Manual{rpact2024,
  title        = {rpact: Confirmatory Adaptive Clinical Trial Design and Analysis},
  author       = {Gernot Wassmer and Friedrich Pahlke},
  year         = {2024},
  note         = {R package version 4.1},
  url          = {https://www.rpact.com}
}

@Manual{TrialSize2020,
    title = {TrialSize: R Functions for Chapter 3,4,6,7,9,10,11,12,14,15 of Sample Size
Calculation in Clinical Research},
    author = {Ed Zhang and Vicky Qian Wu and Shein-Chung Chow and Harry G.Zhang},
    year = {2024},
    note = {R package version 1.4.1},
    url = {https://CRAN.R-project.org/package=TrialSize},
  }

@Manual{PowerTOST2024,
    title = {PowerTOST: Power and Sample Size for (Bio)Equivalence Studies},
    author = {Detlew Labes and Helmut Schütz and Benjamin Lang},
    year = {2024},
    note = {R package version 1.5-6},
    url = {https://CRAN.R-project.org/package=PowerTOST},
  }

@Misc{Caldwell2022,
  author       = {Aaron R. Caldwell},
  title        = {Exploring Equivalence Testing with the Updated TOSTER R Package},
  year         = {2022},
  howpublished = {PsyArXiv},
  doi          = {10.31234/osf.io/ty8de}
}

@Manual{PASS2024,
  author       = {{NCSS LLC}},
  title        = {PASS 2024: Power Analysis \& Sample Size},
  year         = {2024},
  url          = {https://www.ncss.com/software/pass/},
  note         = {Accessed: 15 Oct 2024}
}

@Manual{nQuery2024,
  author       = {{Statsols}},
  title        = {nQuery: Design Efficient, Informative and Adaptive Trials},
  year         = {2024},
  url          = {https://www.statsols.com},
  note         = {Accessed: 15 Oct 2024}
}

@techreport{CHMP2010,
  author       = {{Committee for Medicinal Products for Human Use (CHMP)}},
  title        = {Guideline on the Investigation of Bioequivalence},
  year         = {2010},
  month = jan,
  number = {CPMP/EWP/QWP/1401/98},
  address = {London, UK},
  institution = {European Medicines Agency},
  url          = {https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-bioequivalence-rev1_en.pdf}
}

@article{schuirmann_comparison_1987,
  title = {A Comparison of the {{Two One-Sided Tests Procedure}} and the {{Power Approach}} for Assessing the Equivalence of Average Bioavailability},
  author = {Schuirmann, Donald J.},
  year = {1987},
  month = dec,
  journal = {Journal of Pharmacokinetics and Biopharmaceutics},
  volume = {15},
  number = {6},
  pages = {657--680},
  issn = {0090-466X},
  doi = {10.1007/BF01068419}
}

@article{shieh_assessing_2022,
  title = {Assessing Individual Equivalence in Parallel Group and Crossover Designs: {{Exact}} Test and Sample Size Procedures},
  shorttitle = {Assessing Individual Equivalence in Parallel Group and Crossover Designs},
  author = {Shieh, Gwowen},
  editor = {Gagniuc, Paul Aurelian},
  year = {2022},
  month = may,
  journal = {PLOS ONE},
  volume = {17},
  number = {5},
  pages = {e0269128},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0269128},
  urldate = {2024-05-26}
}

@article{shin_randomized_2015,
  title = {A {{Randomized}}, {{Phase I Pharmacokinetic Study Comparing SB2}} and {{Infliximab Reference Product}} ({{Remicade}}{\textregistered}) in {{Healthy Subjects}}},
  author = {Shin, Donghoon and Kim, Youngdoe and Kim, Yoo Seok and K{\"o}rnicke, Thomas and Fuhr, Rainard},
  year = {2015},
  month = dec,
  journal = {BioDrugs},
  volume = {29},
  number = {6},
  pages = {381--388},
  issn = {1173-8804, 1179-190X},
  doi = {10.1007/s40259-015-0150-5}
}

@book{sozu_sample_2015,
  title = {Sample {{Size Determination}} in {{Clinical Trials}} with {{Multiple Endpoints}}},
  author = {Sozu, Takashi and Sugimoto, Tomoyuki and Hamasaki, Toshimitsu and Evans, Scott R.},
  year = {2015},
  series = {{{SpringerBriefs}} in {{Statistics}}},
  publisher = {Springer International Publishing},
  address = {Cham},
  doi = {10.1007/978-3-319-22005-5},
  urldate = {2023-03-08},
  isbn = {978-3-319-22004-8 978-3-319-22005-5}
}

@inbook{sozu_continuous_2015,
  title        = {Continuous Primary Endpoints},
  booktitle    = {Sample Size Determination in Clinical Trials with Multiple Endpoints},
  author       = {Sozu, Takashi and Sugimoto, Tomoyuki and Hamasaki, Toshimitsu and Evans, Scott R.},
  year         = {2015},
  pages        = {59--68},
  publisher    = {Springer International Publishing},
  address      = {Cham},
  doi          = {10.1007/978-3-319-22005-5_5},
  urldate      = {2025-02-10},
  isbn         = {978-3-319-22004-8, 978-3-319-22005-5},
  langid       = {english}
}


@incollection{PASSch351,
  title        = {Bioequivalence Tests for AUC and Cmax in a 2x2 Cross-Over Design (Log-Normal Data)},
  author       = {{NCSS}},
  booktitle    = {PASS Sample Size Software},
  chapter      = {351},
  year         = {2025},
  publisher    = {NCSS Statistical Software},
  url          = {https://www.ncss.com/wp-content/themes/ncss/pdf/Procedures/PASS/Bioequivalence_Tests_for_AUC_and_Cmax_in_a_2x2_Cross-Over_Design-Log-Normal_Data.pdf}
}
@incollection{PASSch685,
  title        = {Biosimilarity Tests for the Difference Between Means using a Parallel Two-Group Design},
  author       = {{NCSS}},
  booktitle    = {PASS Sample Size Software},
  chapter      = {685},
  year         = {2025},
  publisher    = {NCSS Statistical Software},
  url          = {https://www.ncss.com/wp-content/themes/ncss/pdf/Procedures/PASS/Biosimilarity_Tests_for_the_Difference_Between_Means_using_a_Parallel_Two-Group_Design.pdf}
}
